Suzanne Craft, PhD
Wake Forest Alzheimer's Disease Research Center · Wake Forest University Health Sciences / Wake Forest School of Medicine · Wake Forest University Health Sciences
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Suzanne Craft, PhD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 04:01 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07756294 · Restoring Vascular and Insulin Function To Augment Anti-Amyloid Therapy in Alzheimer's DiseaseWake Forest University Health Sciences · not yet recruiting · Alzheimer Disease · principal investigator
- Ph2NCT05081219 · SNIFF - Combo INI+EMPA TrialWake Forest University Health Sciences · completed · Mild Cognitive Impairment, Cognitive Impairment, Alzheimer Disease · principal investigator
- Ph2NCT05006599 · SNIFF - 3-Week Aptar CPS DeviceWake Forest University Health Sciences · withdrawn · Mild Cognitive Impairment, Cognitive Impairment, Alzheimer Disease, Early Onset · principal investigator
- Ph2NCT04199767 · SNIFF Multi-Device Study 2Wake Forest University Health Sciences · completed · Mild Cognitive Impairment, Cognitive Impairment · principal investigator
- Ph2NCT03857321 · Study of Nasal Insulin to Fight Forgetfulness - Device StudyWake Forest University Health Sciences · completed · Mild Cognitive Impairment, Cognitive Impairment · principal investigator
- N/ANCT03472664 · Brain Energy for Amyloid Transformation in Alzheimer's Disease StudyWake Forest University Health Sciences · completed · Alzheimer Disease, Mild Cognitive Impairment · principal investigator
- N/ANCT03130036 · Biodistribution of [11C]Acetoacetate/[18F]Fluorodeoxyglucose in Subjects With Risk Factors for Alzheimer's DiseaseWake Forest University Health Sciences · completed · Mild Cognitive Impairment · principal investigator
- N/ANCT03089827 · Biodistribution of [11C]PIB in Patients With Risk Factors for Alzheimer's DiseaseWake Forest University Health Sciences · enrolling by invitation · Alzheimer Disease, Mild Cognitive Impairment · principal investigator
- N/ANCT02984540 · Effect of a Modified Ketogenic-Mediterranean Diet on Alzheimer's DiseaseWake Forest University Health Sciences · completed · Mild Cognitive Impairment, Insulin Resistance · principal investigator
- N/ANCT02463084 · Macronutrient Effects on Alzheimer's Disease (MEAL-2)Wake Forest University Health Sciences · completed · Prediabetic State, Insulin Resistance, Middle Age · principal investigator
- Ph1NCT02462161 · Study of Nasal Insulin to Fight Forgetfulness - Short-Acting Insulin AspartWake Forest University Health Sciences · completed · Alzheimer's Disease, Mild Cognitive Impairment · principal investigator
- Ph2/Ph3NCT01767909 · The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)University of Southern California · completed · Amnestic Mild Cognitive Impairment, Alzheimer's Disease · study director
- Ph2NCT01595646 · Study of Nasal Insulin to Fight Forgetfulness - Long-acting Insulin Detemir - 120 Days (SL120)Wake Forest University Health Sciences · completed · Alzheimer's Disease, Mild Cognitive Impairment · principal investigator
- Ph2NCT01547169 · Study of Nasal Insulin to Fight Forgetfulness - Long-acting Insulin Detemir - 21 DaysUniversity of Washington · completed · Alzheimer's Disease, Mild Cognitive Impairment · principal investigator
- Ph2NCT00438568 · SNIFF 120: Study of Nasal Insulin to Fight Forgetfulness (120 Days)University of Washington · completed · Mild Cognitive Impairment, Alzheimer's Disease · principal investigator
- Ph2NCT00242593 · Rosiglitazone Effects on Cognition for Adults in Later LifeUniversity of Washington · unknown · Mild Cognitive Impairment · principal investigator
- Ph4NCT00212290 · Insulin Resistance and Central Nervous System (CNS) Function in Type 2 DiabetesNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · completed · Insulin Resistance, Type 2 Diabetes Mellitus · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 04:01 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Modified Ketogenic Diet Effects on Alzheimer's Disease Biomarkers and Cognition in Mild Cognitive ImpairmentR01AG055122 · NIA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI SUZANNE CRAFT · fiscal years 2017 to 2022Named on NCT03472664
- Satellite CoreP50AG005136 · NIA · UNIVERSITY OF WASHINGTON · PI DEDRA S BUCHWALD · fiscal years 1985 to 2019Named on NCT02462161, NCT01547169
- Therapeutic Effect of Intranasal Insulin on Cognition, Function, and AD BiomarkerRF1AG041845 · NIA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI SUZANNE CRAFT · fiscal years 2012 to 2017Named on NCT01767909
- Therapeutic Effects of Intranasal Insulin in ADR01AG027415 · NIA · UNIVERSITY OF WASHINGTON · PI SUZANNE CRAFT · fiscal years 2006 to 2008Named on NCT00438568
- The Effects of Rosiglitazone in Patients with MCIR01AG025502 · NIA · SEATTLE INST FOR BIOMEDICAL/CLINICAL RES · PI SUZANNE CRAFT · fiscal years 2005 to 2009Named on NCT00242593
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.